Peanut Allergy Drug Slated for 2018

An Aug. 10, 2005 file photo shows the peanut butter production line at Sunland Inc's peanut plant in Portales, N.M. (AP Photo/Albuquerque Journal, Richard Pipes)
An Aug. 10, 2005 file photo shows the peanut butter production line at Sunland Inc's peanut plant in Portales, N.M. (AP Photo/Albuquerque Journal, Richard Pipes)
An Aug. 10, 2005 file photo shows the peanut butter production line at Sunland Inc’s peanut plant in Portales, N.M. (AP Photo/Albuquerque Journal, Richard Pipes)

 

(CNN) – Peanut allergies are a serious and growing health problem in the Western world, affecting millions of kids and their families.

But a fix could be on the way.

A small French biopharmaceutical company has developed a new product — similar to a nicotine patch — to help allergy sufferers significantly increase their peanut tolerance.

If all goes according to plan, DBV Technologies (DBVT) will begin selling its product to Americans in the first six months of 2018.

READ MORE

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.